Aspen Pharmacare

Aspen Pharmacare Holdings Limited
Company typePublic (JSE: APN)
JSE Limited
IndustryHealth care, pharmaceutical industry
PredecessorLennon Ltd
Founded1850, public 1997, Durban, South Africa
Headquarters
La Lucia Ridge, uMhlanga, KwaZulu-Natal
,
South Africa
Key people
Stephen Saad (Group CE)
ProductsSpecialty branded pharmaceuticals including steriles, injectables, oral solid dose, liquids, semi-solids, biologicals, active pharmaceutical ingredients
RevenueIncreaseR 40,709,000,000 (FY 2023)[1][2]
IncreaseR 16,811,000,000 (FY 2023)[1][3]
Total assetsIncreaseR 134,284,000,000 (FY 2023)[1][4][3]
Total equityIncreaseR 86,236,000,000 (FY 2023)[1][5][3]
OwnerJSE listed
Number of employees
9,100[6]
Websitewww.aspenpharma.com

Aspen Pharmacare Holdings Limited is a public multinational pharmaceutical company headquartered in uMhlanga, South Africa.[7] Founded in 1997,[8] it listed on the Johannesburg Stock Exchange (JSE) in 1998,[9] and purchased South African Druggists in 1999 before expanding into international markets.[10] Currently the largest pharmaceutical company in Africa[11] through aggressive mergers and expansion,[7][12] with major manufacturing sites in locations such as Gqeberha in South Africa,[10] Bad Oldesloe in Germany,[13] Notre-Dame-de-Bondeville in France,[14] and Oss, Netherlands,[15] Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals (ARVs)[16][10] and cancer medications.[17] Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish",[18] and has the rights to sell the product under its own brand name Aspenovax.[19] The company's revenue in 2022 was R38.6 billion (US$2.36 billion).[3][20] In 2016 Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for 5 years in the European Union.

  1. ^ a b c d [1] Aspen 2023
  2. ^ https://www.aspenpharma.com/2021/09/01/aspen-increases-revenue-from-continuing-operations-by-12-to-r378-billion/ [bare URL]
  3. ^ a b c d https://www.aspenpharma.com/wp-content/uploads/2022/08/Aspen-Results-Booklet_YE-June-2022.pdf [bare URL PDF]
  4. ^ https://www.wsj.com/market-data/quotes/ZA/XJSE/APN/financials/annual/balance-sheet [bare URL]
  5. ^ https://www.wsj.com/market-data/quotes/ZA/XJSE/APN/financials [bare URL]
  6. ^ "Group overview – Aspen Pharmacare". Aspen Holdings. 15 May 2022. Retrieved 15 May 2022.
  7. ^ a b Cite error: The named reference simeon2010 was invoked but never defined (see the help page).
  8. ^ Cite error: The named reference 2017_Reff17 was invoked but never defined (see the help page).
  9. ^ Cite error: The named reference asphis was invoked but never defined (see the help page).
  10. ^ a b c "Pharmaceuticals wizard knows potion for success". Bizcommunity. Retrieved 10 March 2023.
  11. ^ "Aspen Pharmacare Sells 6 Prescription Drugs for r18-billion to Swiss Acino Health Group". www.iol.co.za.
  12. ^ Cite error: The named reference Meléndez-OrtizRoffe2009 was invoked but never defined (see the help page).
  13. ^ "GSK expands into emerging markets with Aspen deal". www.telegraph.co.uk. 12 May 2009. Retrieved 10 March 2023.
  14. ^ McKee, Selina (2 January 2014). "GSK transfers thrombosis drugs to Aspen". PharmaTimes. Retrieved 10 March 2023.
  15. ^ "Global pharmaceutical company looks at N.B. for drug-making plant". CBC News. 9 September 2016. Archived from the original on 22 December 2022.
  16. ^ Cite error: The named reference LoucheIdowu2010 was invoked but never defined (see the help page).
  17. ^ Cite error: The named reference auto was invoked but never defined (see the help page).
  18. ^ "Vaccines made in South Africa to stay in Africa, says envoy". CBS17.com. 2 September 2021. Retrieved 10 March 2023.
  19. ^ Cite error: The named reference nyt was invoked but never defined (see the help page).
  20. ^ "News and Insights". www.nasdaq.com. Retrieved 30 October 2024.